Treatment of lupus crisis with IgIV

Intravenous Immunoglobulin (i.v.Ig) has been advocated as efficacious for Systemic Lupus Erytematosus (SLE) and Lupic Nephritis (LN) using high dosages, propitious a prolonged remission of SLE. We show the case of a male patient 16 years old, with SLE diagnosis until 1993, and LN phase IV. He attend...

Full description

Saved in:
Bibliographic Details
Published inRevista alergia Mexico (Tecamachalco, Pueblo, Mexico : 1993) Vol. 45; no. 6; pp. 143 - 146
Main Authors Vázquez García, M J, Olalde Carmona, R, Juárez, J A, Escárcega Barbosa, D
Format Journal Article
LanguageSpanish
Published Mexico 01.11.1998
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Intravenous Immunoglobulin (i.v.Ig) has been advocated as efficacious for Systemic Lupus Erytematosus (SLE) and Lupic Nephritis (LN) using high dosages, propitious a prolonged remission of SLE. We show the case of a male patient 16 years old, with SLE diagnosis until 1993, and LN phase IV. He attend to hospital with a Lupic Crisis, positives ANAs, DNAds, ScL 427, C3 45, C4 13, IgG 179, urinary sediment: leukocytes 30-40 xc, erythrocytes 8-10 xc. Renal failure: BUN 243, seric Cr: 10.16. I.v. Ig administrated 400 mgs k do. And nephrologic assistance, NK. There was improvement after infusion, clinical and serological, persisting with renal failure. The mechanism by which i.v. Ig might have effected improvement in this patient was reviewed. The use in our patient with SLE and LN was satisfactory. Is difficult affirm categorical the outcome or failure of i.v. Ig in patients with SLE, even report founded are only few cases report.
AbstractList BACKGROUNDIntravenous Immunoglobulin (i.v.Ig) has been advocated as efficacious for Systemic Lupus Erytematosus (SLE) and Lupic Nephritis (LN) using high dosages, propitious a prolonged remission of SLE.MATERIAL AND METHODWe show the case of a male patient 16 years old, with SLE diagnosis until 1993, and LN phase IV. He attend to hospital with a Lupic Crisis, positives ANAs, DNAds, ScL 427, C3 45, C4 13, IgG 179, urinary sediment: leukocytes 30-40 xc, erythrocytes 8-10 xc. Renal failure: BUN 243, seric Cr: 10.16. I.v. Ig administrated 400 mgs k do. And nephrologic assistance, NK.RESULTSThere was improvement after infusion, clinical and serological, persisting with renal failure. The mechanism by which i.v. Ig might have effected improvement in this patient was reviewed.CONCLUSIONThe use in our patient with SLE and LN was satisfactory. Is difficult affirm categorical the outcome or failure of i.v. Ig in patients with SLE, even report founded are only few cases report.
Intravenous Immunoglobulin (i.v.Ig) has been advocated as efficacious for Systemic Lupus Erytematosus (SLE) and Lupic Nephritis (LN) using high dosages, propitious a prolonged remission of SLE. We show the case of a male patient 16 years old, with SLE diagnosis until 1993, and LN phase IV. He attend to hospital with a Lupic Crisis, positives ANAs, DNAds, ScL 427, C3 45, C4 13, IgG 179, urinary sediment: leukocytes 30-40 xc, erythrocytes 8-10 xc. Renal failure: BUN 243, seric Cr: 10.16. I.v. Ig administrated 400 mgs k do. And nephrologic assistance, NK. There was improvement after infusion, clinical and serological, persisting with renal failure. The mechanism by which i.v. Ig might have effected improvement in this patient was reviewed. The use in our patient with SLE and LN was satisfactory. Is difficult affirm categorical the outcome or failure of i.v. Ig in patients with SLE, even report founded are only few cases report.
Author Olalde Carmona, R
Vázquez García, M J
Escárcega Barbosa, D
Juárez, J A
Author_xml – sequence: 1
  givenname: M J
  surname: Vázquez García
  fullname: Vázquez García, M J
  organization: Servicio de inmunología clínica y alergia, CMN 20 de Noviembre, ISSSTE, México
– sequence: 2
  givenname: R
  surname: Olalde Carmona
  fullname: Olalde Carmona, R
– sequence: 3
  givenname: J A
  surname: Juárez
  fullname: Juárez, J A
– sequence: 4
  givenname: D
  surname: Escárcega Barbosa
  fullname: Escárcega Barbosa, D
BackLink https://www.ncbi.nlm.nih.gov/pubmed/9951325$$D View this record in MEDLINE/PubMed
BookMark eNotj8tqwzAQRbVISZO0n1AQFLozaGSNbC9L6MMQ6MZ0a2RplLj4Vcmm9O8bqFeHC4cLZ882wzjQhu2EEDJBQLhl-xi_rgsLrbZsWxQIqcQde6wCmbmnYeaj590yLZHb0MY28p92vvDyXH7esRtvukj3Kw-sen2pju_J6eOtPD6fkglTTHyjG9C6oFy7XKBTKBvjhFcSlXdOespQKcwzsOiJBDbKkAdhHSBaC-mBPf3fTmH8XijOdd9GS11nBhqXWOsCMqFBXcWHVVyanlw9hbY34bdeo9I__JNHxA
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Tratamiento de crisis lúpica con IgIV
EndPage 146
ExternalDocumentID 9951325
Genre English Abstract
Journal Article
Case Reports
GroupedDBID 77H
ABDBF
ADBBV
ADCUG
AEGXH
ALMA_UNASSIGNED_HOLDINGS
APOWU
BAWUL
BCNDV
CGR
CUY
CVF
DIK
EBD
ECM
EIF
EML
EMOBN
ESX
F5P
FRP
GROUPED_DOAJ
GX1
M~E
NPM
OK1
SV3
TUS
W2D
ZXP
~8M
7X8
ID FETCH-LOGICAL-p535-fb6b1669e86d805d452bad0f4254fdd2fe75445871c5fee05b4aef10cd155cc13
ISSN 0002-5151
IngestDate Thu Apr 11 15:17:41 EDT 2024
Sat Sep 28 07:33:00 EDT 2024
IsPeerReviewed false
IsScholarly false
Issue 6
Language Spanish
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p535-fb6b1669e86d805d452bad0f4254fdd2fe75445871c5fee05b4aef10cd155cc13
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Report-3
ObjectType-Case Study-4
PMID 9951325
PQID 69170614
PQPubID 23479
PageCount 4
ParticipantIDs proquest_miscellaneous_69170614
pubmed_primary_9951325
PublicationCentury 1900
PublicationDate 1998 Nov-Dec
19981101
PublicationDateYYYYMMDD 1998-11-01
PublicationDate_xml – month: 11
  year: 1998
  text: 1998 Nov-Dec
PublicationDecade 1990
PublicationPlace Mexico
PublicationPlace_xml – name: Mexico
PublicationTitle Revista alergia Mexico (Tecamachalco, Pueblo, Mexico : 1993)
PublicationTitleAlternate Rev Alerg Mex
PublicationYear 1998
SSID ssj0025964
Score 1.2933809
Snippet Intravenous Immunoglobulin (i.v.Ig) has been advocated as efficacious for Systemic Lupus Erytematosus (SLE) and Lupic Nephritis (LN) using high dosages,...
BACKGROUNDIntravenous Immunoglobulin (i.v.Ig) has been advocated as efficacious for Systemic Lupus Erytematosus (SLE) and Lupic Nephritis (LN) using high...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 143
SubjectTerms Acute Disease
Adolescent
Humans
Immunoglobulins, Intravenous - therapeutic use
Lupus Erythematosus, Systemic - therapy
Lupus Nephritis - therapy
Male
Title Treatment of lupus crisis with IgIV
URI https://www.ncbi.nlm.nih.gov/pubmed/9951325
https://search.proquest.com/docview/69170614
Volume 45
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swGBVpYaMvpd1W1vVm6N6ChxVLqvVYek1G2j1kpW9B13SQJiGOoeTX95Pk2F5poduLsC1jbB370_kuOkbou4Z5QBmegJPDOzEYPBVn2kJjTpixMlXE6xb0b9j1b9K7p_etVrdRtVQs5A-1fHVdyf-gCscAV7dK9h-QrS4KB2Ab8IUWEIb2fRhXVeJA-cbFrMjbYAScxIgPr3ZH3bsm-XR5ACCDbZgT5qM_ot03T_AeOI45MEo8CvUgxsqHTn8VRoaczOocHzjgzbDsnc-x4yVMLMv2FXwvfv_ck9F-nW26HYuxNq6wBIZF_FWi2CvCJeYhit2r46oXuSq7lBkJnxSZ5qIuUNbVuj1chSlq0wvkCTdNb1CSLF-xph3FQbupgeHs0YPIgRGmYan0C53ssmcNraXY1Xaed39WnjflQUdsdQ8b6EN5-tuOhScYgy20WXoG0WmAeRu1TP4JfeyXtQ-f0XGFdjS1kUc7CmhHDu3Iof0FDS4vBmfXcfmLi3hGUxpbySRmjJuM6SyhmtCOFDqxYEiJ1bpjjdMnpODUuqJAk1BJhLE4URpooFI43UHrk-nEfEVRxpTOLLa6QwQBFihVSolKLNfsJNE83UVHqwcdggVxaSExMdMiHzLuJJQw2UU74fmHsyB0MizH6NtbHXtoo4Z6H60v5oU5AI62kId-_J8B_Wk3vw
link.rule.ids 315,783,787
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Treatment+of+lupus+crisis+with+IgIV&rft.jtitle=Revista+alergia+Mexico+%28Tecamachalco%2C+Pueblo%2C+Mexico+%3A+1993%29&rft.au=V%C3%A1zquez+Garc%C3%ADa%2C+M+J&rft.au=Olalde+Carmona%2C+R&rft.au=Ju%C3%A1rez%2C+J+A&rft.au=Esc%C3%A1rcega+Barbosa%2C+D&rft.date=1998-11-01&rft.issn=0002-5151&rft.volume=45&rft.issue=6&rft.spage=143&rft_id=info%3Apmid%2F9951325&rft.externalDocID=9951325
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-5151&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-5151&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-5151&client=summon